Net Cash Provided by (Used in) Operating Activities |
202K |
USD |
|
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
105K |
USD |
|
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-393K |
USD |
+0.19% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
20M |
shares |
0% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
9.35M |
shares |
+1.26% |
Q3 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.75M |
USD |
+38.6% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
10.2M |
USD |
+2.73% |
Q2 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
9.6M |
USD |
-20% |
Q4 2022 |
Q2 2023 |
Operating Lease, Liability |
2.78M |
USD |
-8.03% |
Q2 2024 |
FY 2024 |
Depreciation |
53.1K |
USD |
+16.5% |
Q3 2024 |
Q1 2025 |
Payments to Acquire Property, Plant, and Equipment |
357K |
USD |
+14.2% |
Q3 2024 |
Q1 2025 |
Lessee, Operating Lease, Liability, to be Paid |
3.51M |
USD |
-9.78% |
Q2 2024 |
FY 2024 |
Property, Plant and Equipment, Gross |
8.45M |
USD |
-3.75% |
Q2 2024 |
FY 2024 |
Operating Lease, Liability, Current |
243K |
USD |
+5.38% |
Q3 2024 |
Q1 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year Two |
380K |
USD |
0% |
Q2 2024 |
FY 2024 |
Lessee, Operating Lease, Liability, to be Paid, Year One |
380K |
USD |
0% |
Q2 2024 |
FY 2024 |
Operating Lease, Weighted Average Discount Rate, Percent |
0.05 |
pure |
0% |
Q2 2024 |
FY 2024 |
Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
724K |
USD |
-15.9% |
Q2 2024 |
FY 2024 |
Lessee, Operating Lease, Liability, to be Paid, Year Three |
380K |
USD |
0% |
Q2 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
8.51M |
USD |
+3.55% |
Q2 2024 |
FY 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2024 |
FY 2024 |
Lessee, Operating Lease, Liability, to be Paid, Year Four |
380K |
USD |
0% |
Q2 2024 |
FY 2024 |
Depreciation, Depletion and Amortization |
67.6K |
USD |
-15.9% |
Q3 2022 |
Q1 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
693K |
USD |
-6.94% |
Q2 2024 |
FY 2024 |